Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol as an Add-on Treatment to Substance Abuse in Juvenile Patients with Psychosis
2024-514393-44-00Phase 2Completed
- Sponsor
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Toxic Psychosis and cannabis use disorder (CUD) comparing Cannabidiol add-on with Placebo add-on (2 arms). Started Sep 2024; status: completed.
02
Drugs
cannabidiol
03
Conditions
Toxic Psychosiscannabis use disorder (CUD)
Beyond the preview
Go deeper on 2024-514393-44-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514393-44-00.